Diagonal Bio AB (publ) DIABIO.ST Stock
0.1 SEK
{{ price }}
26.092390%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
6.66M SEK
LOW - HIGH [24H]
0.08
-
0.13 SEK
VOLUME [24H]
5.63M SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.38 SEK
Diagonal Bio AB (publ) Price Chart
Diagonal Bio AB (publ) DIABIO.ST Financial and Trading Overview
| Diagonal Bio AB (publ) stock price | 0.1 SEK |
| Previous Close | 0.29 SEK |
| Open | 0.29 SEK |
| Bid | 0.28 SEK x N/A |
| Ask | 0.29 SEK x N/A |
| Day's Range | 0.28 - 0.29 SEK |
| 52 Week Range | 0.27 - 7.82 SEK |
| Volume | 23.34K SEK |
| Avg. Volume | 260.41K SEK |
| Market Cap | 10.19M SEK |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.38 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DIABIO.ST Valuation Measures
| Enterprise Value | 397.18K SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4527621 |
| Price/Book (mrq) | 0.369483 |
| Enterprise Value/Revenue | 0.096 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Diagonal Bio AB (publ) Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -94.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.82 SEK |
| 52 Week Low | 0.27 SEK |
| 50-Day Moving Average | 0.43 SEK |
| 200-Day Moving Average | 1.24 SEK |
DIABIO.ST Share Statistics
| Avg. Volume (3 month) | 260.41K SEK |
| Avg. Daily Volume (10-Days) | 254.49K SEK |
| Shares Outstanding | 34.77M |
| Float | 23.4M |
| Short Ratio | N/A |
| % Held by Insiders | 32.11% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -372.95% |
| Gross Margin | 64.19% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.16% |
| Return on Equity (ttm) | -56.78% |
Income Statement
| Revenue (ttm) | 4.15M SEK |
| Revenue Per Share (ttm) | 0.26 SEK |
| Quarterly Revenue Growth (yoy) | 76.70% |
| Gross Profit (ttm) | 2.05M SEK |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -16480000 SEK |
| Diluted EPS (ttm) | -1.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.74M SEK |
| Total Cash Per Share (mrq) | 0.28 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.739 |
| Book Value Per Share (mrq) | 0.793 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15094000 SEK |
| Levered Free Cash Flow (ttm) | -13366500 SEK |
Profile of Diagonal Bio AB (publ)
| Country | Sweden |
| State | N/A |
| City | Lund |
| Address | The Spark |
| ZIP | 223 81 |
| Phone | 46 7 35 26 27 59 |
| Website | https://diagonalbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was incorporated in 2020 and is headquartered in Lund, Sweden.
Q&A For Diagonal Bio AB (publ) Stock
What is a current DIABIO.ST stock price?
Diagonal Bio AB (publ) DIABIO.ST stock price today per share is 0.1 SEK.
How to purchase Diagonal Bio AB (publ) stock?
You can buy DIABIO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diagonal Bio AB (publ)?
The stock symbol or ticker of Diagonal Bio AB (publ) is DIABIO.ST.
Which industry does the Diagonal Bio AB (publ) company belong to?
The Diagonal Bio AB (publ) industry is Biotechnology.
How many shares does Diagonal Bio AB (publ) have in circulation?
The max supply of Diagonal Bio AB (publ) shares is 65.96M.
What is Diagonal Bio AB (publ) Price to Earnings Ratio (PE Ratio)?
Diagonal Bio AB (publ) PE Ratio is now.
What was Diagonal Bio AB (publ) earnings per share over the trailing 12 months (TTM)?
Diagonal Bio AB (publ) EPS is -0.38 SEK over the trailing 12 months.
Which sector does the Diagonal Bio AB (publ) company belong to?
The Diagonal Bio AB (publ) sector is Healthcare.
Diagonal Bio AB (publ) DIABIO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}